Global Radioimmunoassays Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 82718
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Radioimmunoassays market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Radioimmunoassays size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Radioimmunoassays market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Radioimmunoassays market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Balance Method

Sequential Saturation Method

Market segment by Application, can be divided into

Pharmaceutical

Medical Testing

Oncology

Others

Market segment by players, this report covers

Immunoshop India Pvt Ltd.

Institute Of Isotopes Co. Ltd

Instrumentation Laboratory Co.

Novartis Vaccines & Diagnostics Inc.

Sysmex

Trinity Biotech Plc

Weifang 3v Bioengineering Group Co. Ltd.

Weifang Kanghua Biotech Co. Ltd.

Abbott Diagnostics

Acon Laboratories Inc.

Amar Immunodiagnostics

Bayer Ag

Beckman Coulter Inc.

Xiamen Boson Biotech Co. Ltd.

Jei Daniel Biotech Corp.

Labor Diagnostika Nord Gmbh & Co. Kg

Micropoint Bioscience Inc.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Radioimmunoassays product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Radioimmunoassays, with revenue, gross margin and global market share of Radioimmunoassays from 2019 to 2021.

Chapter 3, the Radioimmunoassays competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Radioimmunoassays market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Radioimmunoassays research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Radioimmunoassays

1.2 Classification of Radioimmunoassays by Type

1.2.1 Overview: Global Radioimmunoassays Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Radioimmunoassays Revenue Market Share by Type in 2020

1.2.3 Balance Method

1.2.4 Sequential Saturation Method

1.3 Global Radioimmunoassays Market by Application

1.3.1 Overview: Global Radioimmunoassays Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Pharmaceutical

1.3.3 Medical Testing

1.3.4 Oncology

1.3.5 Others

1.4 Global Radioimmunoassays Market Size & Forecast

1.5 Global Radioimmunoassays Market Size and Forecast by Region

1.5.1 Global Radioimmunoassays Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Radioimmunoassays Market Size by Region, (2016-2021)

1.5.3 North America Radioimmunoassays Market Size and Prospect (2016-2026)

1.5.4 Europe Radioimmunoassays Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Radioimmunoassays Market Size and Prospect (2016-2026)

1.5.6 South America Radioimmunoassays Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Radioimmunoassays Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Radioimmunoassays Market Drivers

1.6.2 Radioimmunoassays Market Restraints

1.6.3 Radioimmunoassays Trends Analysis

2 Company Profiles

2.1 Immunoshop India Pvt Ltd.

2.1.1 Immunoshop India Pvt Ltd. Details

2.1.2 Immunoshop India Pvt Ltd. Major Business

2.1.3 Immunoshop India Pvt Ltd. Radioimmunoassays Product and Solutions

2.1.4 Immunoshop India Pvt Ltd. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Immunoshop India Pvt Ltd. Recent Developments and Future Plans

2.2 Institute Of Isotopes Co. Ltd

2.2.1 Institute Of Isotopes Co. Ltd Details

2.2.2 Institute Of Isotopes Co. Ltd Major Business

2.2.3 Institute Of Isotopes Co. Ltd Radioimmunoassays Product and Solutions

2.2.4 Institute Of Isotopes Co. Ltd Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Institute Of Isotopes Co. Ltd Recent Developments and Future Plans

2.3 Instrumentation Laboratory Co.

2.3.1 Instrumentation Laboratory Co. Details

2.3.2 Instrumentation Laboratory Co. Major Business

2.3.3 Instrumentation Laboratory Co. Radioimmunoassays Product and Solutions

2.3.4 Instrumentation Laboratory Co. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Instrumentation Laboratory Co. Recent Developments and Future Plans

2.4 Novartis Vaccines & Diagnostics Inc.

2.4.1 Novartis Vaccines & Diagnostics Inc. Details

2.4.2 Novartis Vaccines & Diagnostics Inc. Major Business

2.4.3 Novartis Vaccines & Diagnostics Inc. Radioimmunoassays Product and Solutions

2.4.4 Novartis Vaccines & Diagnostics Inc. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Novartis Vaccines & Diagnostics Inc. Recent Developments and Future Plans

2.5 Sysmex

2.5.1 Sysmex Details

2.5.2 Sysmex Major Business

2.5.3 Sysmex Radioimmunoassays Product and Solutions

2.5.4 Sysmex Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Sysmex Recent Developments and Future Plans

2.6 Trinity Biotech Plc

2.6.1 Trinity Biotech Plc Details

2.6.2 Trinity Biotech Plc Major Business

2.6.3 Trinity Biotech Plc Radioimmunoassays Product and Solutions

2.6.4 Trinity Biotech Plc Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Trinity Biotech Plc Recent Developments and Future Plans

2.7 Weifang 3v Bioengineering Group Co. Ltd.

2.7.1 Weifang 3v Bioengineering Group Co. Ltd. Details

2.7.2 Weifang 3v Bioengineering Group Co. Ltd. Major Business

2.7.3 Weifang 3v Bioengineering Group Co. Ltd. Radioimmunoassays Product and Solutions

2.7.4 Weifang 3v Bioengineering Group Co. Ltd. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Weifang 3v Bioengineering Group Co. Ltd. Recent Developments and Future Plans

2.8 Weifang Kanghua Biotech Co. Ltd.

2.8.1 Weifang Kanghua Biotech Co. Ltd. Details

2.8.2 Weifang Kanghua Biotech Co. Ltd. Major Business

2.8.3 Weifang Kanghua Biotech Co. Ltd. Radioimmunoassays Product and Solutions

2.8.4 Weifang Kanghua Biotech Co. Ltd. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Weifang Kanghua Biotech Co. Ltd. Recent Developments and Future Plans

2.9 Abbott Diagnostics

2.9.1 Abbott Diagnostics Details

2.9.2 Abbott Diagnostics Major Business

2.9.3 Abbott Diagnostics Radioimmunoassays Product and Solutions

2.9.4 Abbott Diagnostics Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Abbott Diagnostics Recent Developments and Future Plans

2.10 Acon Laboratories Inc.

2.10.1 Acon Laboratories Inc. Details

2.10.2 Acon Laboratories Inc. Major Business

2.10.3 Acon Laboratories Inc. Radioimmunoassays Product and Solutions

2.10.4 Acon Laboratories Inc. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Acon Laboratories Inc. Recent Developments and Future Plans

2.11 Amar Immunodiagnostics

2.11.1 Amar Immunodiagnostics Details

2.11.2 Amar Immunodiagnostics Major Business

2.11.3 Amar Immunodiagnostics Radioimmunoassays Product and Solutions

2.11.4 Amar Immunodiagnostics Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Amar Immunodiagnostics Recent Developments and Future Plans

2.12 Bayer Ag

2.12.1 Bayer Ag Details

2.12.2 Bayer Ag Major Business

2.12.3 Bayer Ag Radioimmunoassays Product and Solutions

2.12.4 Bayer Ag Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Bayer Ag Recent Developments and Future Plans

2.13 Beckman Coulter Inc.

2.13.1 Beckman Coulter Inc. Details

2.13.2 Beckman Coulter Inc. Major Business

2.13.3 Beckman Coulter Inc. Radioimmunoassays Product and Solutions

2.13.4 Beckman Coulter Inc. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Beckman Coulter Inc. Recent Developments and Future Plans

2.14 Xiamen Boson Biotech Co. Ltd.

2.14.1 Xiamen Boson Biotech Co. Ltd. Details

2.14.2 Xiamen Boson Biotech Co. Ltd. Major Business

2.14.3 Xiamen Boson Biotech Co. Ltd. Radioimmunoassays Product and Solutions

2.14.4 Xiamen Boson Biotech Co. Ltd. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Xiamen Boson Biotech Co. Ltd. Recent Developments and Future Plans

2.15 Jei Daniel Biotech Corp.

2.15.1 Jei Daniel Biotech Corp. Details

2.15.2 Jei Daniel Biotech Corp. Major Business

2.15.3 Jei Daniel Biotech Corp. Radioimmunoassays Product and Solutions

2.15.4 Jei Daniel Biotech Corp. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Jei Daniel Biotech Corp. Recent Developments and Future Plans

2.16 Labor Diagnostika Nord Gmbh & Co. Kg

2.16.1 Labor Diagnostika Nord Gmbh & Co. Kg Details

2.16.2 Labor Diagnostika Nord Gmbh & Co. Kg Major Business

2.16.3 Labor Diagnostika Nord Gmbh & Co. Kg Radioimmunoassays Product and Solutions

2.16.4 Labor Diagnostika Nord Gmbh & Co. Kg Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Labor Diagnostika Nord Gmbh & Co. Kg Recent Developments and Future Plans

2.17 Micropoint Bioscience Inc.

2.17.1 Micropoint Bioscience Inc. Details

2.17.2 Micropoint Bioscience Inc. Major Business

2.17.3 Micropoint Bioscience Inc. Radioimmunoassays Product and Solutions

2.17.4 Micropoint Bioscience Inc. Radioimmunoassays Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Micropoint Bioscience Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Radioimmunoassays Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Radioimmunoassays Players Market Share

3.2.2 Top 10 Radioimmunoassays Players Market Share

3.2.3 Market Competition Trend

3.3 Radioimmunoassays Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Radioimmunoassays Revenue and Market Share by Type (2016-2021)

4.2 Global Radioimmunoassays Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Radioimmunoassays Revenue Market Share by Application (2016-2021)

5.2 Radioimmunoassays Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Radioimmunoassays Revenue by Type (2016-2026)

6.2 North America Radioimmunoassays Revenue by Application (2016-2026)

6.3 North America Radioimmunoassays Market Size by Country

6.3.1 North America Radioimmunoassays Revenue by Country (2016-2026)

6.3.2 United States Radioimmunoassays Market Size and Forecast (2016-2026)

6.3.3 Canada Radioimmunoassays Market Size and Forecast (2016-2026)

6.3.4 Mexico Radioimmunoassays Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Radioimmunoassays Revenue by Type (2016-2026)

7.2 Europe Radioimmunoassays Revenue by Application (2016-2026)

7.3 Europe Radioimmunoassays Market Size by Country

7.3.1 Europe Radioimmunoassays Revenue by Country (2016-2026)

7.3.2 Germany Radioimmunoassays Market Size and Forecast (2016-2026)

7.3.3 France Radioimmunoassays Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Radioimmunoassays Market Size and Forecast (2016-2026)

7.3.5 Russia Radioimmunoassays Market Size and Forecast (2016-2026)

7.3.6 Italy Radioimmunoassays Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Radioimmunoassays Revenue by Type (2016-2026)

8.2 Asia-Pacific Radioimmunoassays Revenue by Application (2016-2026)

8.3 Asia-Pacific Radioimmunoassays Market Size by Region

8.3.1 Asia-Pacific Radioimmunoassays Revenue by Region (2016-2026)

8.3.2 China Radioimmunoassays Market Size and Forecast (2016-2026)

8.3.3 Japan Radioimmunoassays Market Size and Forecast (2016-2026)

8.3.4 South Korea Radioimmunoassays Market Size and Forecast (2016-2026)

8.3.5 India Radioimmunoassays Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Radioimmunoassays Market Size and Forecast (2016-2026)

8.3.7 Australia Radioimmunoassays Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Radioimmunoassays Revenue by Type (2016-2026)

9.2 South America Radioimmunoassays Revenue by Application (2016-2026)

9.3 South America Radioimmunoassays Market Size by Country

9.3.1 South America Radioimmunoassays Revenue by Country (2016-2026)

9.3.2 Brazil Radioimmunoassays Market Size and Forecast (2016-2026)

9.3.3 Argentina Radioimmunoassays Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Radioimmunoassays Revenue by Type (2016-2026)

10.2 Middle East & Africa Radioimmunoassays Revenue by Application (2016-2026)

10.3 Middle East & Africa Radioimmunoassays Market Size by Country

10.3.1 Middle East & Africa Radioimmunoassays Revenue by Country (2016-2026)

10.3.2 Turkey Radioimmunoassays Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Radioimmunoassays Market Size and Forecast (2016-2026)

10.3.4 UAE Radioimmunoassays Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Radioimmunoassays Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Radioimmunoassays Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Radioimmunoassays Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Radioimmunoassays Revenue (USD Million) by Region (2016-2021)

Table 5. Global Radioimmunoassays Revenue Market Share by Region (2021-2026)

Table 6. Immunoshop India Pvt Ltd. Corporate Information, Head Office, and Major Competitors

Table 7. Immunoshop India Pvt Ltd. Major Business

Table 8. Immunoshop India Pvt Ltd. Radioimmunoassays Product and Solutions

Table 9. Immunoshop India Pvt Ltd. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Institute Of Isotopes Co. Ltd Corporate Information, Head Office, and Major Competitors

Table 11. Institute Of Isotopes Co. Ltd Major Business

Table 12. Institute Of Isotopes Co. Ltd Radioimmunoassays Product and Solutions

Table 13. Institute Of Isotopes Co. Ltd Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Instrumentation Laboratory Co. Corporate Information, Head Office, and Major Competitors

Table 15. Instrumentation Laboratory Co. Major Business

Table 16. Instrumentation Laboratory Co. Radioimmunoassays Product and Solutions

Table 17. Instrumentation Laboratory Co. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Novartis Vaccines & Diagnostics Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Novartis Vaccines & Diagnostics Inc. Major Business

Table 20. Novartis Vaccines & Diagnostics Inc. Radioimmunoassays Product and Solutions

Table 21. Novartis Vaccines & Diagnostics Inc. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Sysmex Corporate Information, Head Office, and Major Competitors

Table 23. Sysmex Major Business

Table 24. Sysmex Radioimmunoassays Product and Solutions

Table 25. Sysmex Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Trinity Biotech Plc Corporate Information, Head Office, and Major Competitors

Table 27. Trinity Biotech Plc Major Business

Table 28. Trinity Biotech Plc Radioimmunoassays Product and Solutions

Table 29. Trinity Biotech Plc Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Weifang 3v Bioengineering Group Co. Ltd. Corporate Information, Head Office, and Major Competitors

Table 31. Weifang 3v Bioengineering Group Co. Ltd. Major Business

Table 32. Weifang 3v Bioengineering Group Co. Ltd. Radioimmunoassays Product and Solutions

Table 33. Weifang 3v Bioengineering Group Co. Ltd. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Weifang Kanghua Biotech Co. Ltd. Corporate Information, Head Office, and Major Competitors

Table 35. Weifang Kanghua Biotech Co. Ltd. Major Business

Table 36. Weifang Kanghua Biotech Co. Ltd. Radioimmunoassays Product and Solutions

Table 37. Weifang Kanghua Biotech Co. Ltd. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Abbott Diagnostics Corporate Information, Head Office, and Major Competitors

Table 39. Abbott Diagnostics Major Business

Table 40. Abbott Diagnostics Radioimmunoassays Product and Solutions

Table 41. Abbott Diagnostics Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Acon Laboratories Inc. Corporate Information, Head Office, and Major Competitors

Table 43. Acon Laboratories Inc. Major Business

Table 44. Acon Laboratories Inc. Radioimmunoassays Product and Solutions

Table 45. Acon Laboratories Inc. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Amar Immunodiagnostics Corporate Information, Head Office, and Major Competitors

Table 47. Amar Immunodiagnostics Major Business

Table 48. Amar Immunodiagnostics Radioimmunoassays Product and Solutions

Table 49. Amar Immunodiagnostics Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Bayer Ag Corporate Information, Head Office, and Major Competitors

Table 51. Bayer Ag Major Business

Table 52. Bayer Ag Radioimmunoassays Product and Solutions

Table 53. Bayer Ag Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Beckman Coulter Inc. Corporate Information, Head Office, and Major Competitors

Table 55. Beckman Coulter Inc. Major Business

Table 56. Beckman Coulter Inc. Radioimmunoassays Product and Solutions

Table 57. Beckman Coulter Inc. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Xiamen Boson Biotech Co. Ltd. Corporate Information, Head Office, and Major Competitors

Table 59. Xiamen Boson Biotech Co. Ltd. Major Business

Table 60. Xiamen Boson Biotech Co. Ltd. Radioimmunoassays Product and Solutions

Table 61. Xiamen Boson Biotech Co. Ltd. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Jei Daniel Biotech Corp. Corporate Information, Head Office, and Major Competitors

Table 63. Jei Daniel Biotech Corp. Major Business

Table 64. Jei Daniel Biotech Corp. Radioimmunoassays Product and Solutions

Table 65. Jei Daniel Biotech Corp. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Labor Diagnostika Nord Gmbh & Co. Kg Corporate Information, Head Office, and Major Competitors

Table 67. Labor Diagnostika Nord Gmbh & Co. Kg Major Business

Table 68. Labor Diagnostika Nord Gmbh & Co. Kg Radioimmunoassays Product and Solutions

Table 69. Labor Diagnostika Nord Gmbh & Co. Kg Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Micropoint Bioscience Inc. Corporate Information, Head Office, and Major Competitors

Table 71. Micropoint Bioscience Inc. Major Business

Table 72. Micropoint Bioscience Inc. Radioimmunoassays Product and Solutions

Table 73. Micropoint Bioscience Inc. Radioimmunoassays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global Radioimmunoassays Revenue (USD Million) by Players (2019-2021)

Table 75. Global Radioimmunoassays Revenue Share by Players (2019-2021)

Table 76. Breakdown of Radioimmunoassays by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Radioimmunoassays Players Head Office, Products and Services Provided

Table 78. Radioimmunoassays Mergers & Acquisitions in the Past Five Years

Table 79. Radioimmunoassays New Entrants and Expansion Plans

Table 80. Global Radioimmunoassays Revenue (USD Million) by Type (2016-2021)

Table 81. Global Radioimmunoassays Revenue Share by Type (2016-2021)

Table 82. Global Radioimmunoassays Revenue Forecast by Type (2021-2026)

Table 83. Global Radioimmunoassays Revenue by Application (2016-2021)

Table 84. Global Radioimmunoassays Revenue Forecast by Application (2021-2026)

Table 85. North America Radioimmunoassays Revenue by Type (2016-2021) & (USD Million)

Table 86. North America Radioimmunoassays Revenue by Type (2021-2026) & (USD Million)

Table 87. North America Radioimmunoassays Revenue by Application (2016-2021) & (USD Million)

Table 88. North America Radioimmunoassays Revenue by Application (2021-2026) & (USD Million)

Table 89. North America Radioimmunoassays Revenue by Country (2016-2021) & (USD Million)

Table 90. North America Radioimmunoassays Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe Radioimmunoassays Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe Radioimmunoassays Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe Radioimmunoassays Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe Radioimmunoassays Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe Radioimmunoassays Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe Radioimmunoassays Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific Radioimmunoassays Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific Radioimmunoassays Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific Radioimmunoassays Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific Radioimmunoassays Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific Radioimmunoassays Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific Radioimmunoassays Revenue by Region (2021-2026) & (USD Million)

Table 103. South America Radioimmunoassays Revenue by Type (2016-2021) & (USD Million)

Table 104. South America Radioimmunoassays Revenue by Type (2021-2026) & (USD Million)

Table 105. South America Radioimmunoassays Revenue by Application (2016-2021) & (USD Million)

Table 106. South America Radioimmunoassays Revenue by Application (2021-2026) & (USD Million)

Table 107. South America Radioimmunoassays Revenue by Country (2016-2021) & (USD Million)

Table 108. South America Radioimmunoassays Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa Radioimmunoassays Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa Radioimmunoassays Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa Radioimmunoassays Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa Radioimmunoassays Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa Radioimmunoassays Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa Radioimmunoassays Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Radioimmunoassays Picture

Figure 2. Global Radioimmunoassays Revenue Market Share by Type in 2020

Figure 3. Balance Method

Figure 4. Sequential Saturation Method

Figure 5. Radioimmunoassays Revenue Market Share by Application in 2020

Figure 6. Pharmaceutical Picture

Figure 7. Medical Testing Picture

Figure 8. Oncology Picture

Figure 9. Others Picture

Figure 10. Global Radioimmunoassays Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Radioimmunoassays Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Radioimmunoassays Revenue Market Share by Region (2016-2026)

Figure 13. Global Radioimmunoassays Revenue Market Share by Region in 2020

Figure 14. North America Radioimmunoassays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Radioimmunoassays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Radioimmunoassays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Radioimmunoassays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Radioimmunoassays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Radioimmunoassays Market Drivers

Figure 20. Radioimmunoassays Market Restraints

Figure 21. Radioimmunoassays Market Trends

Figure 22. Immunoshop India Pvt Ltd. Recent Developments and Future Plans

Figure 23. Institute Of Isotopes Co. Ltd Recent Developments and Future Plans

Figure 24. Instrumentation Laboratory Co. Recent Developments and Future Plans

Figure 25. Novartis Vaccines & Diagnostics Inc. Recent Developments and Future Plans

Figure 26. Sysmex Recent Developments and Future Plans

Figure 27. Trinity Biotech Plc Recent Developments and Future Plans

Figure 28. Weifang 3v Bioengineering Group Co. Ltd. Recent Developments and Future Plans

Figure 29. Weifang Kanghua Biotech Co. Ltd. Recent Developments and Future Plans

Figure 30. Abbott Diagnostics Recent Developments and Future Plans

Figure 31. Acon Laboratories Inc. Recent Developments and Future Plans

Figure 32. Amar Immunodiagnostics Recent Developments and Future Plans

Figure 33. Bayer Ag Recent Developments and Future Plans

Figure 34. Beckman Coulter Inc. Recent Developments and Future Plans

Figure 35. Xiamen Boson Biotech Co. Ltd. Recent Developments and Future Plans

Figure 36. Jei Daniel Biotech Corp. Recent Developments and Future Plans

Figure 37. Labor Diagnostika Nord Gmbh & Co. Kg Recent Developments and Future Plans

Figure 38. Micropoint Bioscience Inc. Recent Developments and Future Plans

Figure 39. Global Radioimmunoassays Revenue Share by Players in 2020

Figure 40. Radioimmunoassays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players Radioimmunoassays Revenue Market Share in 2020

Figure 42. Global Top 10 Players Radioimmunoassays Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global Radioimmunoassays Revenue Share by Type in 2020

Figure 45. Global Radioimmunoassays Market Share Forecast by Type (2021-2026)

Figure 46. Global Radioimmunoassays Revenue Share by Application in 2020

Figure 47. Global Radioimmunoassays Market Share Forecast by Application (2021-2026)

Figure 48. North America Radioimmunoassays Sales Market Share by Type (2016-2026)

Figure 49. North America Radioimmunoassays Sales Market Share by Application (2016-2026)

Figure 50. North America Radioimmunoassays Revenue Market Share by Country (2016-2026)

Figure 51. United States Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe Radioimmunoassays Sales Market Share by Type (2016-2026)

Figure 55. Europe Radioimmunoassays Sales Market Share by Application (2016-2026)

Figure 56. Europe Radioimmunoassays Revenue Market Share by Country (2016-2026)

Figure 57. Germany Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific Radioimmunoassays Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific Radioimmunoassays Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific Radioimmunoassays Revenue Market Share by Region (2016-2026)

Figure 65. China Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America Radioimmunoassays Sales Market Share by Type (2016-2026)

Figure 72. South America Radioimmunoassays Sales Market Share by Application (2016-2026)

Figure 73. South America Radioimmunoassays Revenue Market Share by Country (2016-2026)

Figure 74. Brazil Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa Radioimmunoassays Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa Radioimmunoassays Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa Radioimmunoassays Revenue Market Share by Country (2016-2026)

Figure 79. Turkey Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE Radioimmunoassays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source